Replies to post #137902 on Biotech Values

[ghmm]

I think its been mentioned previously on this board but those ruling out a foreign stock just on liquidity of the PK use symbol may want to reconsider. I've purchased a number of foreign stocks of the years (mainly Canadian) that trade with a US pink sheet equivalent and with absolute certainty I know my volume was NOT reflected in the pink sheet that day. I don't know the specifics on how the trade is executed/cleared but if the foreign market the stock trades under has the liquidity I think one could trade it near the exchange rate price and not the typically larger Pink Sheet spread. I suggest the best way is to manually do the conversion in price to US dollars and then USE A LIMIT ORDER!

I did a quick search on Medivir and if I got the symbol right on the Stockhom exchange the volume should create a lot of liquidity... well at least for most of us I imagine :-)
http://finance.yahoo.com/q/hp?s=MVIR-B.ST+Historical+Prices

On Medivir I don't generally go after HCV companies but it may be interesting. I seem to recall though aren't they partnered with J&J. Does anyone know what economics they have and if their other drugs are partnered? OK I will admit I am too lazy to do the initial DD to decide if its worth looking at deeper :-).

[bladerunner1717]

oc631,

After listening to the whole Medivir CC, I think it is fair to infer that they believe that IFN and Riba are dead and never coming back (eventually). The CEO believes that two DAAs without IFN and without Riba will ultimately win the day. Do you agree?


Bladerunner

[mcbio]

If GS-7977/Riba has viral relapse problems in GT1 treatment-naive patients it could be a wildly bullish event for Medivir.

When are these results due?

Positive data for 7977/Riba in GT1's shouldn't cause significant downside for Medivir so in this respect it would be good trade IMO.

I'm inclined to agree because I think the goal is to ultimately remove riba as well. I think this is another reason why the 7977+TMC435 combo study is so important because they are testing both drugs with and without riba (http://www.medivir.se/v4/en/ir_media/pressrelease.cfm?year=2011&releaseid=587686 ).